Summit Therapeutics
SMMT
11 hedge funds and large institutions have $29.6M invested in Summit Therapeutics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
38% more funds holding
Funds holding: 8 → 11 (+3)
11% less capital invested
Capital invested by funds: $33.2M → $29.6M (-$3.57M)
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$1.72M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LPU
1
Lansdowne Partners (UK)
London,
United Kingdom
| $9.82M | – | – | – |
|
2
Point72 Asset Management
Stamford,
Connecticut
| $9.63M | +$777K | +68,603 | +8% |
|
3
Axa
Paris,
France
| $3.09M | – | – | – |
|
|
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
| $2.28M | +$342K | +30,200 | +17% |
|
5
First Eagle Investment Management
New York
| $1.94M | – | – | – |
|
|
GPCM
6
Granite Point Capital Management
Boston,
Massachusetts
| $1.35M | +$35.8K | +3,157 | +3% |
|
|
EAM
7
EverPoint Asset Management
Stamford,
Connecticut
| $1.06M | +$1.13M | +100,000 | New |
|
|
AIC
8
AWM Investment Company
New York
| $451K | +$484K | +42,693 | New |
|
9
UBS Group
Zurich,
Switzerland
| $2K | +$2.27K | +200 | New |
|
10
Citigroup
New York
| $1K | +$600 | +53 | New |
|
|
11
Janus Henderson Group
London,
United Kingdom
| – | -$1.72M | -139,166 | Closed |
|
12
Morgan Stanley
New York
| – | +$91 | +8 | New |
|
SMMT Hedge Fund Activity: Q2 2015 in Review
11 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q2 2015, worth a combined $29.6M — down 11% from $33.2M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SMMT positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $1.13M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $1.72M sold.
- 11 institutional investors held Summit Therapeutics (SMMT) as of Q2 2015, up from 8 in Q1 2015.
- Funds reported $29.6M of Summit Therapeutics stock for Q2 2015, down 11% quarter-over-quarter.
- 5 funds opened new Summit Therapeutics positions in Q2 2015 and 2 closed out, a net change of +3 holders.
- The largest Summit Therapeutics buyer in Q2 2015 was EverPoint Asset Management, an estimated $1.13M added.
- The largest Summit Therapeutics seller in Q2 2015 was Janus Henderson Group, an estimated $1.72M sold.
Based on aggregated 13F filings for Q2 2015.